Cargando…

Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy

OBJECTIVES: To translate the SWAMECO from German into English; to complete content and face validity with healthcare professionals (HCPs) and with patients from the target population that is, community-dwelling adult patients taking three or more medicines for three or more months. DESIGN: The proce...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnet, Isabelle, Messerli, Markus, Oezvegyi, Jana, Hersberger, Kurt, Sahm, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430483/
https://www.ncbi.nlm.nih.gov/pubmed/32801198
http://dx.doi.org/10.1136/bmjopen-2020-036761
_version_ 1783571435722113024
author Arnet, Isabelle
Messerli, Markus
Oezvegyi, Jana
Hersberger, Kurt
Sahm, Laura
author_facet Arnet, Isabelle
Messerli, Markus
Oezvegyi, Jana
Hersberger, Kurt
Sahm, Laura
author_sort Arnet, Isabelle
collection PubMed
description OBJECTIVES: To translate the SWAMECO from German into English; to complete content and face validity with healthcare professionals (HCPs) and with patients from the target population that is, community-dwelling adult patients taking three or more medicines for three or more months. DESIGN: The process followed guidance from Sousa et al and included translation and cross-cultural adaptation, and cognitive testing among selected HCPs and patients. As the SWAMECO questionnaire is a screening instrument, pilot testing was performed in the target population. SETTING: Three community pharmacies in and around Cork (Ireland) recruited patients for interviews and pilot testing. PARTICIPANTS: Community-dwelling patients with ≥3 oral medications for ≥3 months, aged ≥18 years. OUTCOME MEASURES: Answers to the SWAMECO questionnaire; clarity of each question, each instruction and each response format. RESULTS: Issues related to cultural and conceptual differences were resolved by rewording some items. Ten HCPs and 11 patients completed the questionnaire and gave their feedback and opinions on criteria according to Fitzpatrick et al. Revisions included rewording; deleting of two questions; using of colour to signpost that is, where to skip questions that were not applicable to the participants; and replacement of the A-14 medication adherence scale with three validated items. Of the 66 patients enrolled for pilot testing, eight (12.1%) indicated swallowing difficulties. Difficulties with ingesting foods or liquids correlated with swallowing difficulties (p=0.001). All patients perceived discomfort (mean 6.9 on a Visual Analogue Scale from 0 to 10). Patients with swallowing difficulties were significantly more likely to report modifying their medicines (p=0.004) and having poorer medication adherence (p=0.028) than those who had no swallowing difficulties. CONCLUSIONS: The version of the SWAMECO questionnaire in English contains 28 items and is ready for use in adults with polypharmacy.
format Online
Article
Text
id pubmed-7430483
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74304832020-08-24 Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy Arnet, Isabelle Messerli, Markus Oezvegyi, Jana Hersberger, Kurt Sahm, Laura BMJ Open Public Health OBJECTIVES: To translate the SWAMECO from German into English; to complete content and face validity with healthcare professionals (HCPs) and with patients from the target population that is, community-dwelling adult patients taking three or more medicines for three or more months. DESIGN: The process followed guidance from Sousa et al and included translation and cross-cultural adaptation, and cognitive testing among selected HCPs and patients. As the SWAMECO questionnaire is a screening instrument, pilot testing was performed in the target population. SETTING: Three community pharmacies in and around Cork (Ireland) recruited patients for interviews and pilot testing. PARTICIPANTS: Community-dwelling patients with ≥3 oral medications for ≥3 months, aged ≥18 years. OUTCOME MEASURES: Answers to the SWAMECO questionnaire; clarity of each question, each instruction and each response format. RESULTS: Issues related to cultural and conceptual differences were resolved by rewording some items. Ten HCPs and 11 patients completed the questionnaire and gave their feedback and opinions on criteria according to Fitzpatrick et al. Revisions included rewording; deleting of two questions; using of colour to signpost that is, where to skip questions that were not applicable to the participants; and replacement of the A-14 medication adherence scale with three validated items. Of the 66 patients enrolled for pilot testing, eight (12.1%) indicated swallowing difficulties. Difficulties with ingesting foods or liquids correlated with swallowing difficulties (p=0.001). All patients perceived discomfort (mean 6.9 on a Visual Analogue Scale from 0 to 10). Patients with swallowing difficulties were significantly more likely to report modifying their medicines (p=0.004) and having poorer medication adherence (p=0.028) than those who had no swallowing difficulties. CONCLUSIONS: The version of the SWAMECO questionnaire in English contains 28 items and is ready for use in adults with polypharmacy. BMJ Publishing Group 2020-08-16 /pmc/articles/PMC7430483/ /pubmed/32801198 http://dx.doi.org/10.1136/bmjopen-2020-036761 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Arnet, Isabelle
Messerli, Markus
Oezvegyi, Jana
Hersberger, Kurt
Sahm, Laura
Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy
title Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy
title_full Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy
title_fullStr Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy
title_full_unstemmed Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy
title_short Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy
title_sort translation to english, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (swameco) for adults with polypharmacy
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430483/
https://www.ncbi.nlm.nih.gov/pubmed/32801198
http://dx.doi.org/10.1136/bmjopen-2020-036761
work_keys_str_mv AT arnetisabelle translationtoenglishcrossculturaladaptationandpilottestingoftheselfreportquestionnaireonswallowingdifficultieswithmedicationintakeandcopingstrategiesswamecoforadultswithpolypharmacy
AT messerlimarkus translationtoenglishcrossculturaladaptationandpilottestingoftheselfreportquestionnaireonswallowingdifficultieswithmedicationintakeandcopingstrategiesswamecoforadultswithpolypharmacy
AT oezvegyijana translationtoenglishcrossculturaladaptationandpilottestingoftheselfreportquestionnaireonswallowingdifficultieswithmedicationintakeandcopingstrategiesswamecoforadultswithpolypharmacy
AT hersbergerkurt translationtoenglishcrossculturaladaptationandpilottestingoftheselfreportquestionnaireonswallowingdifficultieswithmedicationintakeandcopingstrategiesswamecoforadultswithpolypharmacy
AT sahmlaura translationtoenglishcrossculturaladaptationandpilottestingoftheselfreportquestionnaireonswallowingdifficultieswithmedicationintakeandcopingstrategiesswamecoforadultswithpolypharmacy